Madrigal Pharmaceuticals
MDGL
$440.13
Share price
-2.79%
Change (1 day)
22.11%
Change (1 year)
Categories
Revenue for Madrigal Pharmaceuticals (MDGL)
Revenue in 2024 (TTM): S$0.23 Billion
According to Madrigal Pharmaceuticals
's latest financial reports the company's current revenue (TTM 
) is S$0.24 Billion. an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Madrigal Pharmaceuticals from 2008 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | S$0.24 B | |
| 2023 | N/A | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | -100% |
| 2012 | S$0.17 M | -98.17% |
| 2011 | S$9.82 M | -48.49% |
| 2010 | S$19.06 M | -90.58% |
| 2009 | S$0.20 B | 2989.06% |
| 2008 | S$6.55 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | S$0.3 M | -99.87% | 🇺🇸 USA |
 | S$0.95 B | 295.90% | 🇺🇸 USA |